A solution center to solve a medical mystery
A solution chemistry lab in the United States could help solve a mystery about how people who developed lung cancer can breathe without a mask.
A U.S. company called The Solution Center has developed a unique technology that allows patients to breathe with only their nose and mouth.
It’s not clear whether the new technology will work for all lung cancer patients.
A large study of more than 1,300 patients who had the cancer found that some were able to breathe without using a mask, though the researchers cautioned that this study had some limitations.
The new technology could also help doctors, as the technology could help them diagnose the disease before it has advanced to the point of requiring a full-body mask, which can take weeks.
The technology was first used in a pilot study of a lung cancer patient who was able to inhale a large dose of a drug that contained air bubbles, the New York Times reported on Thursday.
But the company’s research is far from a breakthrough.
It’s still unclear how the technology works and how long it could be used, and some experts are skeptical of the company.
The company has raised more than $50 million in venture capital from a handful of investors, including Andreessen Horowitz, Andreessen Media and others, to develop and test the technology.
The idea of the new lung cancer treatment system came from an idea by Dr. William T. Ritter, a lung surgeon at Harvard Medical School who developed a device to breathe through the nose and a different method to breathe from the mouth.
The technology has also been used in the treatment of multiple sclerosis, Parkinson’s disease and Parkinson’s syndrome.
“In my case, I’ve been using the nose as my mask for about 15 years, and it’s been great,” said Dr. Daniel F. W. Smith, an assistant professor of medicine at the University of California, San Francisco, who has studied the lung cancer disease.
The device can be installed in a patient’s chest or a nasal mask, depending on the patient’s preference.
When an air bubble enters the patient, the device will draw the air and press it against the skin.
When it’s time to breathe, the air bubbles release and the patient exhales through the mouth or nose.
If it works, this could mean that the technology would work for everyone with lung cancer.
The company is still developing the technology, which it hopes to start offering as a treatment option by the end of 2018.
The study of 1,302 people with lung disease was the first of its kind, and the researchers have not found that any of the patients who used the device could breathe without masks.
The researchers said they did not have enough data to determine how long people can breathe with the device, but they also said that while the technology does not work for most lung cancer cases, there are some people who can breathe through their nose.
The research was published in the journal Nature Medicine.
Follow Mike Wall on Twitter at michaeldwall and Google+.
Follow us @livescience, Facebook & Google+.
Original article on LiveScience.